Previous BCG vaccination is associated with less severe clinical progression of COVID-19

被引:0
作者
Susan Martins Pereira
Florisneide Rodrigues Barreto
Ramon Andrade de Souza
Carlos Antonio de Souza Teles Santos
Marcos Pereira
Enny Santos da Paixão
Carla Cristina Oliveira de Jesus Lima
Marcio Santos da Natividade
Ana Angélica Bulcão Portela Lindoso
Eder Gatti Fernandes
Evonio Barros Campelo Junior
Julia Moreira Pescarini
Kaio Vinicius Freitas de Andrade
Fernanda Mattos de Souza
Elisangela Alves de Britto
Ceuci Nunes
Maria Yuri Ichihara
Margareth Dalcolmo
Anete Trajman
Manoel Barral-Netto
Ibrahim Abubakar
Mauricio Lima Barreto
Ricardo Arraes de Alencar Ximenes
Laura Cunha Rodrigues
机构
[1] Federal University of Bahia,Institute of Collective Health
[2] Center for Data and Knowledge Integration for Health (CIDACS),Department of Exact Sciences
[3] State University of Feira de Santana,Institute of Infectology
[4] Faculty of Epidemiology,Department of Tropical Medicine, Health Sciences Center
[5] London School of Hygiene and Tropical Medicine,Health Department
[6] Emílio Ribas-SES-SP,Institute of Social Medicine
[7] Federal University of Pernambuco,State Department of Health of Bahia
[8] Universidade Estadual de Feira de Santana,Departamento de Clínica Médica
[9] University of the State of Rio de Janeiro,McGill TB International Centre
[10] Institute Couto Maia,Faculdade de Medicina
[11] Hélio Fraga Reference Center,Institute for Global Health
[12] Fundação Oswaldo Cruz (Fiocruz),undefined
[13] Universidade Federal do Rio de Janeiro,undefined
[14] McGill University,undefined
[15] Institute Gonçalo Moniz - Fundação Oswaldo Cruz (Fiocruz),undefined
[16] Federal University of Bahia,undefined
[17] University College London,undefined
来源
BMC Medicine | / 21卷
关键词
BCG; Bacillus Calmette-Guérin; COVID-19; SARS-CoV-2; Coronavirus disease 2019; Severity; Vaccination;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 177 条
[1]  
Guallar-Garrido S(2020)Bacillus Calmette-Guérin (BCG) therapy for bladder cancer: an update ImmunoTargets Ther. 9 1-11
[2]  
Julián E(2019)Non-specific effects of BCG vaccine on viral infections Clin Microbiol Infect 25 1473-8
[3]  
Moorlag SJCFM(2011)Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis. 204 245-52
[4]  
Arts RJW(2021)BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial Lancet Infect Dis. 21 993-1003
[5]  
van Crevel R(2012)Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact Pediatr Infect Dis J. 31 306-8
[6]  
Netea MG(2005)Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study Vaccine. 23 1251-7
[7]  
Aaby P(2020)Natural and trained innate immunity against Mycobacterium tuberculosis Immunobiology. 225 eabn4002-6
[8]  
Roth A(2022)Neonatal BCG vaccination is associated with a long-term DNA methylation signature in circulating monocytes Sci Adv 8 17720-505
[9]  
Ravn H(2020)BCG vaccine protection from severe coronavirus disease 2019 (COVID-19) Proc Natl Acad Sci U S A. 117 eabc1463-25
[10]  
Napirna BM(2020)Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19 Sci Adv 6 5589-1